ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,678,000 | +16.1% | 1,263,930 | 0.0% | 1.16% | +3.1% |
| Q2 2022 | $17,809,000 | -41.8% | 1,263,930 | 0.0% | 1.13% | -28.2% |
| Q1 2022 | $30,574,000 | +608.1% | 1,263,930 | +583.2% | 1.57% | +835.1% |
| Q4 2021 | $4,318,000 | -71.7% | 185,000 | -50.0% | 0.17% | -68.1% |
| Q3 2020 | $15,263,000 | -14.9% | 370,000 | 0.0% | 0.53% | -33.1% |
| Q2 2020 | $17,934,000 | +14.7% | 370,000 | 0.0% | 0.79% | -26.0% |
| Q1 2020 | $15,633,000 | – | 370,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |